Blood Metabolomic Measures Associate With Present and Future Glycemic Control in Type 2 Diabetes

Leen M. 't Hart*, Nicole Vogelzangs, Dennis O. Mook-Kanamori, Adela Brahimaj, Jana Nano, Amber A. W. A. van der Heijden, Ko Willems van Dijk, Roderick C. Slieker, Ewout W. Steyerberg, M. Arfan Ikram, Marian Beekman, Dorret I. Boomsma, Cornelia M. van Duijn, P. Eline Slagboom, Coen D. A. Stehouwer, Casper G. Schalkwijk, Ilja C. W. Arts, Jacqueline M. Dekker, Abbas Dehghan, Taulant MukaCarla J. H. van der Kallen, Giel Nijpels, Marleen M. J. van Greevenbroek

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)4569-4579
Number of pages11
JournalJournal of Clinical Endocrinology & Metabolism
Volume103
Issue number12
DOIs
Publication statusPublished - Dec 2018

Keywords

  • MAGNETIC-RESONANCE METABOLOMICS
  • INSULIN-RESISTANCE
  • AMINO-ACIDS
  • EPIDEMIOLOGY
  • HYPERGLYCEMIA
  • DETERMINANTS
  • PROGRESSION
  • PREDICT
  • DESIGN
  • RISK

Cite this

't Hart, L. M., Vogelzangs, N., Mook-Kanamori, D. O., Brahimaj, A., Nano, J., van der Heijden, A. A. W. A., van Dijk, K. W., Slieker, R. C., Steyerberg, E. W., Ikram, M. A., Beekman, M., Boomsma, D. I., van Duijn, C. M., Slagboom, P. E., Stehouwer, C. D. A., Schalkwijk, C. G., Arts, I. C. W., Dekker, J. M., Dehghan, A., ... van Greevenbroek, M. M. J. (2018). Blood Metabolomic Measures Associate With Present and Future Glycemic Control in Type 2 Diabetes. Journal of Clinical Endocrinology & Metabolism, 103(12), 4569-4579. https://doi.org/10.1210/jc.2018-01165